Picture of HPC Biosciences logo

535217 HPC Biosciences Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro Cap

Annual cashflow statement for HPC Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
R2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSInterim ReportPRESSPRESS
Standards:
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5.773.5911.9-4.81-4.13
Depreciation
Non-Cash Items-0.715-1.02-0.854-4.17-3.72
Other Non-Cash Items
Changes in Working Capital-0.475-0.438-2.454.8-0.658
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities11.78.2313.70.851-3.48
Capital Expenditures0000
Purchase of Fixed Assets
Other Investing Cash Flow Items-9.63-7.92-13.78.11-3.53
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-9.63-7.92-13.78.11-3.53
Financing Cash Flow Items00000
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities00000
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.120.3050.0298.96-7.01